Skip to Main Content

Paper Details

Batf2 differentially regulates tissue immunopathology in Type 1 and Type 2 diseases.
Mucosal Immunol
17
2019
Basic leucine zipper transcription factor 2, Batf2, Batf2-/-, Listeria monocytogenes, Lm, Mtb, Mycobacterium tuberculosis, TB, Type 1 and Type 2 diseases, Type 1-controlled infectious diseases, batf2 mRNA, early death, human, human macrophages, infectious diseases, intestinal fibro-granulomatous inflammation, leucine, mice, mouse, patients, pro-fibrotic immune cells, pulmonary inflammatory macrophage, schistosomiasis, tuberculosis, wasting disease
Author NameAffiliation
Reto GulerInternational Centre for Genetic Engineering and Biotechnology (ICGEB)
Reto GulerUniversity of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases
Reto GulerInstitute of Infectious Diseases and Molecular Medicine (IDM), University of Cape Town
Sugata RoyRIKEN Center for Integrative Medical Sciences
Harukazu SuzukiRIKEN Center for Integrative Medical Sciences
Harukazu SuzukiRIKEN Center for Integrative Medical Sciences
Frank BrombacherInternational Centre for Genetic Engineering and Biotechnology (ICGEB)
Frank BrombacherUniversity of Cape Town, Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases
Frank BrombacherInstitute of Infectious Diseases and Molecular Medicine (IDM), University of Cape Town
  • 1 - 9

Datasets

Release 1.2